Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism

Journal of Immunology

Volumn 168, Issue 2, 2002, Pages 689-695

  Mazzoni, A ^a   Bronte, V ^a   Visintin, A ^a   Spitzer, J H ^a   Apolloni, E ^a   Serafini, P ^a   Zanovello, P ^a   Segal, D M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD69 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGENIC AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEPTIDE DERIVATIVE; STAT5 PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; FEMALE; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYMPHOCYTE FUNCTION; LYMPHOID ORGAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0037080021     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.2.689     Document Type: Article

References (39)

1. + T cell responses by dysregulating antigen-presenting cell maturation
2. Mechanisms of tumor-induced immunosuppression: Evidence for contact-dependent T cell suppression by monocytes
3. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing TGF-β and nitric oxide
4. Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes
5. Augmentation of an antitumor CTL response in vivo by inhibition of suppressor macrophage nitric oxide
6. + myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation
7. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor
8. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF
9. Resection of solid tumors reverses T cell defects and restores protective immunity
10. + cells
11. + cells in the spleen of cyclophosphamide-treated mice: Implications for T-cell responses in immunosuppressed mice
12. Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
13. Nitric oxide mediation of active immunosuppression associated with graft-versus-host reaction
14. Immunosuppression induced by attenuated Salmonella: Evidence for mediation by macrophage precursors
15. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins
16. Immunosuppression in hamsters with progressive visceral leishmaniasis: An evaluation of the role of nitric oxide toward impairment of the lymphoproliferative response
17. Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-γ
18. Nitric oxide involvement in tumor-induced immunosuppression
19. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing ζ molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity
20. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 ζ chain of T-cell receptor complex and antigen-specific T-cell responses
21. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Janus kinase 3 expression and IL-2 receptor signaling: Role of soluble products from human renal cell carcinomas
22. Depletion of IL-10- and TGF-β-producing regulatory γδ T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells
23. Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation in tumor-associated macrophages
24. Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-γ stimulation through a mechanism dependent on endogenous TNF-α and IL-1α
25. Splenic macrophages from tumor-bearing mice co-expressing MAC-1 and MAC-2 antigens exert immuno-regulatory functions via two distinct mechanisms
26. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: Role of IFN-γ in the induction of the nitric oxide-synthesizing pathway
27. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes
28. 10 thymocytes in vivo
29. Biology of the interleukin-2 receptor
30. NO as a signaling molecule: Effects on kinases
31. Redox signaling: Nitrosylation and related target interactions of nitric oxide
32. Regulation of cytosolic guanylyl cyclase by nitric oxide: The NO-cyclic GMP signal transduction system
33. Nitric oxide and thiol redox regulation of Janus kinase activity
34. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Janus kinase 3/STAT5 signaling pathway
35. Nitric oxide and macrophage function
36. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1
37. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene
38. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis
39. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon γ, nitric oxide, and apoptosis